CC
ELEV
Caxton Corporation’s Elevation Oncology ELEV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-21,813
| Closed | -$14.5K | – | 14 |
|
|
2023
Q3 | $14.5K | Buy |
21,813
+88
| +0.4% | +$58 | 0.05% | 9 |
|
|
2023
Q2 | $33K | Sell |
21,725
-46,599
| -68% | -$70.8K | 0.1% | 7 |
|
|
2023
Q1 | $130K | Hold |
68,324
| – | – | 0.33% | 12 |
|
|
2022
Q4 | $64.8K | Buy |
68,324
+27
| +0% | +$26 | 0.17% | 14 |
|
|
2022
Q3 | $77K | Buy |
68,297
+4
| +0% | +$5 | 0.14% | 12 |
|
|
2022
Q2 | $96K | Buy |
68,293
+14
| +0% | +$20 | 0.13% | 11 |
|
|
2022
Q1 | $172K | Buy |
68,279
+12,980
| +23% | +$32.7K | 0.21% | 32 |
|
|
2021
Q4 | $333K | Buy |
55,299
+7,116
| +15% | +$42.9K | 0.27% | 41 |
|
|
2021
Q3 | $375K | Buy |
48,183
+8,597
| +22% | +$66.9K | 0.3% | 43 |
|
|
2021
Q2 | $537K | Buy |
+39,586
| New | +$537K | 0.37% | 40 |
|